These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17541610)

  • 21. Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines.
    Johnsen A; France J; Sy MS; Harding CV
    Cancer Res; 1998 Aug; 58(16):3660-7. PubMed ID: 9721876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in laryngeal squamous cell carcinoma].
    Zeng Q; Wang XL; Xu ZG; Lü N; Zheng S; Zhao QZ; Tang PZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):234-40. PubMed ID: 22805026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major histocompatibility antigens and antigen-processing molecules in uveal melanoma.
    Krishnakumar S; Abhyankar D; Sundaram AL; Pushparaj V; Shanmugam MP; Biswas J
    Clin Cancer Res; 2003 Sep; 9(11):4159-64. PubMed ID: 14519640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mutation in the ATP-binding region of JAK1, identified in human uterine leiomyosarcomas, results in defective interferon-gamma inducibility of TAP1 and LMP2.
    Hayashi T; Kobayashi Y; Kohsaka S; Sano K
    Oncogene; 2006 Jul; 25(29):4016-26. PubMed ID: 16474838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced expression of the transporter associated with antigen processing 1 molecule in malignant glioma cells, and its restoration by interferon-gamma and -beta.
    Satoh E; Mabuchi T; Satoh H; Asahara T; Nukui H; Naganuma H
    J Neurosurg; 2006 Feb; 104(2):264-71. PubMed ID: 16509500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions.
    Vitale M; Rezzani R; Rodella L; Zauli G; Grigolato P; Cadei M; Hicklin DJ; Ferrone S
    Cancer Res; 1998 Feb; 58(4):737-42. PubMed ID: 9485029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival.
    Lou Y; Vitalis TZ; Basha G; Cai B; Chen SS; Choi KB; Jeffries AP; Elliott WM; Atkins D; Seliger B; Jefferies WA
    Cancer Res; 2005 Sep; 65(17):7926-33. PubMed ID: 16140964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells.
    Miyagi T; Tatsumi T; Takehara T; Kanto T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
    J Gastroenterol Hepatol; 2003 Jan; 18(1):32-40. PubMed ID: 12519221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers.
    Kloor M; Becker C; Benner A; Woerner SM; Gebert J; Ferrone S; von Knebel Doeberitz M
    Cancer Res; 2005 Jul; 65(14):6418-24. PubMed ID: 16024646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells.
    Leone P; Shin EC; Perosa F; Vacca A; Dammacco F; Racanelli V
    J Natl Cancer Inst; 2013 Aug; 105(16):1172-87. PubMed ID: 23852952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
    Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
    Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.
    Ritz U; Momburg F; Pilch H; Huber C; Maeurer MJ; Seliger B
    Int J Oncol; 2001 Dec; 19(6):1211-20. PubMed ID: 11713591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
    Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
    Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: association with disease progression.
    Liu Q; Hao C; Su P; Shi J
    Scand J Gastroenterol; 2009; 44(8):960-9. PubMed ID: 19492245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
    Ogino T; Shigyo H; Ishii H; Katayama A; Miyokawa N; Harabuchi Y; Ferrone S
    Cancer Res; 2006 Sep; 66(18):9281-9. PubMed ID: 16982773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression.
    Kageshita T; Hirai S; Ono T; Hicklin DJ; Ferrone S
    Am J Pathol; 1999 Mar; 154(3):745-54. PubMed ID: 10079252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of transporters associated with antigen processing and human leucocyte antigen class I in malignant melanoma and its association with prognostic factors.
    Tao J; Li Y; Liu YQ; Li L; Liu J; Shen X; Shen GX; Tu YT
    Br J Dermatol; 2008 Jan; 158(1):88-94. PubMed ID: 17999701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis.
    Kamarashev J; Ferrone S; Seifert B; Böni R; Nestle FO; Burg G; Dummer R
    Int J Cancer; 2001 Jan; 95(1):23-8. PubMed ID: 11241306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.
    Kovalcsik E; John J; Turner M; Birchall L; Sage D; Whittle R; Dalgleish A; Pandha H
    Melanoma Res; 2004 Dec; 14(6):463-71. PubMed ID: 15577316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.